Nitrogen-containing heterocyclic compound for treating cerebral apoplexy

A compound, stroke technology, applied in the field of medicinal chemistry, achieves good therapeutic activity and broadens the range of effects

Pending Publication Date: 2021-02-12
THE SECOND PEOPLES HOSPITAL OF SHENZHEN
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] To sum up, although various chemical and natural medicines are in different research stages, th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitrogen-containing heterocyclic compound for treating cerebral apoplexy
  • Nitrogen-containing heterocyclic compound for treating cerebral apoplexy
  • Nitrogen-containing heterocyclic compound for treating cerebral apoplexy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Embodiment 1: the synthesis of compound I

[0023] Compound 2 (283mg, 1.5mmol), HOAt (273mg, 2mmol), PyAOP (1044mg, 2mmol), DIPEA (347μL, 2mmol) and 10mL DMSO were added to a 150mL three-necked flask, stirred for 15min, and compound 3 (198mg, 1mmol) of DMSO (10mL) solution, after adding, stir and react at room temperature for 18h. After the reaction is detected by TLC, add 20mL water and 30mL dichloromethane, stand for liquid separation after extraction, and separate the organic phase through silica gel column chromatography to obtain yellow The target product I was a brown solid, with a yield of 49% and a purity of 97.6% by HPLC.

[0024] Molecular formula: C 19 h 19 N 3 o 5 ;ESI-MS: 370.72[M+H] +

[0025] 1 H NMR (400MHz, CDCl 3 )δ1.90(s, 3H), 2.19(s, 3H), 2.83(s, 1H), 3.12(m, 2H), 4.59(m, 1H), 5.43(d, 2H), 6.63-6.81(m , 3H), 7.60 (m, 2H), 7.85 (m, 2H).

Embodiment 2

[0026] Embodiment 2: The effect of the compound shown in formula I in treating ischemic stroke

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a compound for preventing and treating cerebral apoplexy, particularly ischemic cerebral apoplexy, wherein the compound exhibits good therapeutic activity in a mouse cerebral ischemia reperfusion test, can significantly reduce the proportion of cerebral infarction, and can be used for preventing and treating cerebral apoplexy, particularly ischemic cerebral apoplexy.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a compound for preventing and treating stroke, especially ischemic stroke, and also relates to a preparation method, pharmaceutical composition and use of the compound. Background technique [0002] The results of the third national cause of death survey confirmed that stroke has become the first cause of death in my country, and the annual growth rate exceeds 8.7%, which has seriously affected the lives and health of Chinese people. Stroke is mainly divided into two types: ischemic stroke (IS) and hemorrhagic stroke (HS). Among them, IS type patients account for three-quarters of the total incidence of patients and are the main cause of stroke. Types of. The key to the treatment of IS is "early diagnosis and early intervention". Various current treatments try to save the ischemic brain tissue by recanalizing the blood flow of the early infarcted brain tissue, but its short "t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D231/26A61K31/4152A61P9/10
CPCC07D231/26A61P9/10
Inventor 任力杰谭回胡诗雨冯宏业王洋雷志浩
Owner THE SECOND PEOPLES HOSPITAL OF SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap